These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17694399)

  • 21. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity.
    Kanatani M; Sugimoto T; Kaji H; Kobayashi T; Nishiyama K; Fukase M; Kumegawa M; Chihara K
    J Bone Miner Res; 1995 Nov; 10(11):1681-90. PubMed ID: 8592944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha.
    Tani-Ishii N; Tsunoda A; Teranaka T; Umemoto T
    J Dent Res; 1999 Oct; 78(10):1617-23. PubMed ID: 10520966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin.
    Abe E; Yamamoto M; Taguchi Y; Lecka-Czernik B; O'Brien CA; Economides AN; Stahl N; Jilka RL; Manolagas SC
    J Bone Miner Res; 2000 Apr; 15(4):663-73. PubMed ID: 10780858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are nonresorbing osteoclasts sources of bone anabolic activity?
    Karsdal MA; Martin TJ; Bollerslev J; Christiansen C; Henriksen K
    J Bone Miner Res; 2007 Apr; 22(4):487-94. PubMed ID: 17227224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of osteoclast differentiation and function by phosphate: potential role of osteoclasts in the skeletal abnormalities in hypophosphatemic conditions.
    Hayashibara T; Hiraga T; Sugita A; Wang L; Hata K; Ooshima T; Yoneda T
    J Bone Miner Res; 2007 Nov; 22(11):1743-51. PubMed ID: 17638577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural requirements for the action of parathyroid hormone-related protein (PTHrP) on bone resorption by isolated osteoclasts.
    Evely RS; Bonomo A; Schneider HG; Moseley JM; Gallagher J; Martin TJ
    J Bone Miner Res; 1991 Jan; 6(1):85-93. PubMed ID: 2048435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Bone Morphogenetic Protein Pathway: The Osteoclastic Perspective.
    Lademann F; Hofbauer LC; Rauner M
    Front Cell Dev Biol; 2020; 8():586031. PubMed ID: 33178699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Local factors of bone remodeling].
    Marie PJ; De Vernejoul MC
    Rev Rhum Ed Fr; 1993 Jan; 60(1):54-63. PubMed ID: 8242028
    [No Abstract]   [Full Text] [Related]  

  • 29. BMP and BMP inhibitors in bone.
    Rosen V
    Ann N Y Acad Sci; 2006 Apr; 1068():19-25. PubMed ID: 16831902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of osteoclasts in maintaining calcium homeostasis in newts].
    Berezovskaia OP; Rodionova NV; Grigorian EN; Mitashov VI
    Izv Akad Nauk Ser Biol; 1997; (4):495-9. PubMed ID: 9410269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study on BMP-induced osteoclastogenesis and osteoblastogenesis in primary cultures of adult rat bone marrow cells.
    Paul S; Lee JC; Yeh LC
    Growth Factors; 2009 Apr; 27(2):121-31. PubMed ID: 19180354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo.
    de la Mata J; Uy HL; Guise TA; Story B; Boyce BF; Mundy GR; Roodman GD
    J Clin Invest; 1995 Jun; 95(6):2846-52. PubMed ID: 7769125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posterior lumbar interbody fusion using rhBMP-2.
    Meisel HJ; Schnöring M; Hohaus C; Minkus Y; Beier A; Ganey T; Mansmann U
    Eur Spine J; 2008 Dec; 17(12):1735-44. PubMed ID: 18839225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory regulation of osteoclast bone resorption by signal regulatory protein alpha.
    van Beek EM; de Vries TJ; Mulder L; Schoenmaker T; Hoeben KA; Matozaki T; Langenbach GE; Kraal G; Everts V; van den Berg TK
    FASEB J; 2009 Dec; 23(12):4081-90. PubMed ID: 19667119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro.
    Lakkakorpi PT; Väänänen HK
    J Bone Miner Res; 1991 Aug; 6(8):817-26. PubMed ID: 1664645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone morphogenetic proteins 2, 5, and 6 in combination stimulate osteoblasts but not osteoclasts in vitro.
    Wutzl A; Rauner M; Seemann R; Millesi W; Krepler P; Pietschmann P; Ewers R
    J Orthop Res; 2010 Nov; 28(11):1431-9. PubMed ID: 20872578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Regulation of osteoclast activity: a new approach in the therapy of bone diseases].
    Vanhara P; Smarda J
    Cas Lek Cesk; 2006; 145(8):606-10. PubMed ID: 16995415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural products for treatment of bone erosive diseases: The effects and mechanisms on inhibiting osteoclastogenesis and bone resorption.
    An J; Hao D; Zhang Q; Chen B; Zhang R; Wang Y; Yang H
    Int Immunopharmacol; 2016 Jul; 36():118-131. PubMed ID: 27131574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoclasts and integrins.
    Teitelbaum SL
    Ann N Y Acad Sci; 2006 Apr; 1068():95-9. PubMed ID: 16831909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium-dependent phosphate transporters in osteoclast differentiation and function.
    Albano G; Moor M; Dolder S; Siegrist M; Wagner CA; Biber J; Hernando N; Hofstetter W; Bonny O; Fuster DG
    PLoS One; 2015; 10(4):e0125104. PubMed ID: 25910236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.